{
  "frames" : [ {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-3-54",
    "text" : "PTEN function, which antagonizes phosphoinositide 3-kinase (PI3K) signaling, causes the accumulation of phosphatidylinositol",
    "arguments" : [ {
      "text" : "phosphatidylinositol",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-3-62"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-3-59"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 575,
      "object-type" : "relative-pos"
    },
    "trigger" : "causes",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 451,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-3",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Impaired PTEN function, which antagonizes phosphoinositide 3-kinase (PI3K) signaling, causes the accumulation of phosphatidylinositol (3,4,5)-triphosphate and thereby the suppression of downstream components of the PI3K pathway, including the protein kinase B and mammalian target of rapamycin kinases."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-8-118",
    "text" : "loss of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-8-89"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "decreaseamount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 1689,
      "object-type" : "relative-pos"
    },
    "trigger" : "loss",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 1677,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-8",
    "found-by" : "decrease_amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "Therapeutic strategies for rescuing PTEN deficiency in human cancers are proposed.INTRODUCTIONThe phosphatase and tensin homolog gene, PTEN, is one of the most commonly mutated tumor suppressors in human malignancies [1–5], and complete loss of PTEN protein expression is significantly associated with advanced cancer and poor outcome [6, 7]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-4",
    "text" : "de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase",
    "arguments" : [ {
      "text" : "phosphoinositide 3-kinase",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-3"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "dephosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2341,
      "object-type" : "relative-pos"
    },
    "trigger" : "de-phosphorylates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2218,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "found-by" : "Dephosphorylation_syntax_1a_verb",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "text" : "PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-3",
    "arguments" : [ {
      "text" : "de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-4"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-4"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2341,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2191,
      "object-type" : "relative-pos"
    },
    "found-by" : "Dephosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "text" : "phosphatase that de-phosphorylates phosphatidylinositol",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-43",
    "arguments" : [ {
      "text" : "de-phosphorylates phosphatidylinositol",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-42"
    }, {
      "text" : "phosphatase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-5"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2256,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2201,
      "object-type" : "relative-pos"
    },
    "found-by" : "Dephosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-50",
    "text" : "de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3",
    "arguments" : [ {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-46"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "dephosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2284,
      "object-type" : "relative-pos"
    },
    "trigger" : "de-phosphorylates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2218,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "found-by" : "Dephosphorylation_syntax_1a_verb",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-42",
    "text" : "de-phosphorylates phosphatidylinositol",
    "arguments" : [ {
      "text" : "phosphatidylinositol",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-42"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "dephosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2256,
      "object-type" : "relative-pos"
    },
    "trigger" : "de-phosphorylates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2218,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "found-by" : "Dephosphorylation_syntax_1a_verb",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "text" : "PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-49",
    "arguments" : [ {
      "text" : "de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-50"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-4"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2284,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2191,
      "object-type" : "relative-pos"
    },
    "found-by" : "Dephosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "text" : "phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-5",
    "arguments" : [ {
      "text" : "de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-4"
    }, {
      "text" : "phosphatase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-5"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2341,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2201,
      "object-type" : "relative-pos"
    },
    "found-by" : "Dephosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "text" : "phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-51",
    "arguments" : [ {
      "text" : "de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-50"
    }, {
      "text" : "phosphatase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-5"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2284,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2201,
      "object-type" : "relative-pos"
    },
    "found-by" : "Dephosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "text" : "PTEN is a phosphatase that de-phosphorylates phosphatidylinositol",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-41",
    "arguments" : [ {
      "text" : "de-phosphorylates phosphatidylinositol",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-10-42"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-10-4"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2256,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2191,
      "object-type" : "relative-pos"
    },
    "found-by" : "Dephosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-10",
    "verbose-text" : "Biochemically, PTEN is a phosphatase that de-phosphorylates phosphatidylinositol (3,4,5)-tri-phosphate (PIP3), the lipid product of class I phosphoinositide 3-kinase (PI3K) [10]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-12-115",
    "text" : "loss of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-12-105"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "decreaseamount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2465,
      "object-type" : "relative-pos"
    },
    "trigger" : "loss",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2453,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-12",
    "found-by" : "decrease_amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-12-4" ],
    "verbose-text" : "Unsurprisingly, loss of PTEN has a substantial impact on multiple aspects of cancer development."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-14-139",
    "text" : "phosphatase activity that negatively regulates the cytoplasmic PI3K",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-14-112"
    }, {
      "text" : "phosphatase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-14-111"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2754,
      "object-type" : "relative-pos"
    },
    "trigger" : "negatively regulates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2687,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-14",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "In the cytoplasm, PTEN has intrinsic lipid phosphatase activity that negatively regulates the cytoplasmic PI3K/AKT pathway, whereas in the nucleus, PTEN has AKT-independent growth activities."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-14-138",
    "text" : "phosphatase activity that negatively regulates the cytoplasmic PI3K/AKT",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-14-113"
    }, {
      "text" : "phosphatase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-14-111"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2758,
      "object-type" : "relative-pos"
    },
    "trigger" : "negatively regulates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 2687,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-14",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "In the cytoplasm, PTEN has intrinsic lipid phosphatase activity that negatively regulates the cytoplasmic PI3K/AKT pathway, whereas in the nucleus, PTEN has AKT-independent growth activities."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-15-148",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-15-120"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 3074,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 3059,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-15",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-15-5" ],
    "verbose-text" : "The continued elucidation of the roles of nuclear PTEN will help uncover the various functions of this essential tumor suppressor gene.In this review, we describe the molecular basis of PTEN loss, discuss the regulation of PTEN expression in lymphoid malignancies, and summarize potential therapeutic targets in PTEN-deficient cancers.STRUCTURE AND FUNCTION OF PTENPTEN structurePTEN is a tumor suppressor gene located on chromosome 10q23.31 that encodes for a 403-amino acid protein that has both lipid and protein phosphatase activities."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-22-26",
    "text" : "phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2",
    "arguments" : [ {
      "text" : "CK2",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-22-25"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 4671,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 4593,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-22",
    "found-by" : "Phosphorylation_syntax_2b_verb",
    "verbose-text" : "The C-terminal tail residues phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2) are shown."
  }, {
    "text" : "phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-22-25",
    "arguments" : [ {
      "text" : "phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-22-26"
    }, {
      "text" : "glycogen synthase kinase 3β",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-22-26"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 4671,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 4593,
      "object-type" : "relative-pos"
    },
    "found-by" : "Phosphorylation_syntax_2b_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-22",
    "verbose-text" : "The C-terminal tail residues phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2) are shown."
  }, {
    "text" : "phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-22-27",
    "arguments" : [ {
      "text" : "phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-22-26"
    }, {
      "text" : "casein kinase 2",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-22-27"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 4671,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 4593,
      "object-type" : "relative-pos"
    },
    "found-by" : "Phosphorylation_syntax_2b_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-22",
    "verbose-text" : "The C-terminal tail residues phosphorylated by glycogen synthase kinase 3β (GSK3β) and casein kinase 2 (CK2) are shown."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-26-68",
    "text" : "Ubiquitination of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-26-165"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "ubiquitination",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5050,
      "object-type" : "relative-pos"
    },
    "trigger" : "Ubiquitination",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5028,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-26",
    "found-by" : "Ubiquitination_syntax_1a_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-26-9" ],
    "verbose-text" : "Ubiquitination of PTEN has also been found on K13 and K289.The PI3K/PTEN/AKT/mTOR pathwayPTEN's tumor-suppressing function largely relies on the protein's phosphatase activity and subsequent antagonism of the PI3K/AKT/mammalian target of rapamycin (mTOR) pathway."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-27-156",
    "text" : "PIP3 at the plasma membrane recruits and activates a subset of pleckstrin homology domain",
    "arguments" : [ {
      "text" : "pleckstrin homology domain",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-27-174"
    }, {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-27-172"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5412,
      "object-type" : "relative-pos"
    },
    "trigger" : "activates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5323,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-27",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Following PTEN loss, excessive PIP3 at the plasma membrane recruits and activates a subset of pleckstrin homology domain–containing proteins to the cell membrane."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-29-151",
    "text" : "AKT activation also leads to the activation of the mTOR kinase complex 1 through the inhibition of the phosphorylation of tuberous sclerosis complex tumor suppressors and consequent activation of the small GTPase rat sarcoma (RAS",
    "arguments" : [ {
      "text" : "RAS",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-29-184"
    }, {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-29-178"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5776,
      "object-type" : "relative-pos"
    },
    "trigger" : "leads",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5547,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-29",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "AKT activation also leads to the activation of the mTOR kinase complex 1 through the inhibition of the phosphorylation of tuberous sclerosis complex tumor suppressors and consequent activation of the small GTPase rat sarcoma (RAS) homologue enriched in brain."
  }, {
    "text" : "mTOR complex 1 phosphorylates the p70 ribosomal protein S6 kinase",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-30-11",
    "arguments" : [ {
      "text" : "phosphorylates the p70 ribosomal protein S6 kinase",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-30-12"
    }, {
      "text" : "mTOR",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-30-12"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5883,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5818,
      "object-type" : "relative-pos"
    },
    "found-by" : "Phosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-30",
    "verbose-text" : "The active mTOR complex 1 phosphorylates the p70 ribosomal protein S6 kinase (S6K) and inhibits 4E-binding protein 1 to activate protein translation [16]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-30-12",
    "text" : "phosphorylates the p70 ribosomal protein S6 kinase",
    "arguments" : [ {
      "text" : "ribosomal protein S6 kinase",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-30-11"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5883,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 5833,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-30",
    "found-by" : "Phosphorylation_syntax_1a_verb",
    "verbose-text" : "The active mTOR complex 1 phosphorylates the p70 ribosomal protein S6 kinase (S6K) and inhibits 4E-binding protein 1 to activate protein translation [16]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-34-94",
    "text" : "PIP3-driven tumorigenesis",
    "arguments" : [ {
      "text" : "tumorigenesis",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-34-212"
    }, {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-34-211"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 6905,
      "object-type" : "relative-pos"
    },
    "trigger" : "driven",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 6880,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-34",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Thus, the blockade of PI3K signaling may shift the survival signal to the AKT-independent PTEN-regulated pathway, implicated JNK and AKT as complementary signals in PIP3-driven tumorigenesis and suggest that JNK may be a therapeutic target in PTEN null tumors.In addition to its lipid phosphatase function, PTEN also has lipid phosphatase–independent roles."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-35-88",
    "text" : "PTEN has been shown to inhibit cell migration",
    "arguments" : [ {
      "text" : "cell migration",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-35-219"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-35-218"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 7118,
      "object-type" : "relative-pos"
    },
    "trigger" : "inhibit",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 7073,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-35",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "PTEN has been shown to inhibit cell migration through its C2 domain, independent of PTEN's lipid phosphatase activity [18]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-35-89",
    "text" : "PTEN has been shown to inhibit cell migration through its C2 domain, independent of PTEN's lipid phosphatase",
    "arguments" : [ {
      "text" : "phosphatase",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-35-223"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-35-218"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 7181,
      "object-type" : "relative-pos"
    },
    "trigger" : "inhibit",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 7073,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-35",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "PTEN has been shown to inhibit cell migration through its C2 domain, independent of PTEN's lipid phosphatase activity [18]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-37-112",
    "text" : "P53 protein levels",
    "arguments" : [ {
      "text" : "P53",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-37-235"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 7639,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 7621,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-37",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-37-13" ],
    "verbose-text" : "Furthermore, PTEN has been shown to directly bind to tumor protein 53 (p53), regulate its stability, and increase its transcription, thereby increasing P53 protein levels [20]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-38-107",
    "text" : "hypermethylation of the PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-38-239"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "methylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 8036,
      "object-type" : "relative-pos"
    },
    "trigger" : "hypermethylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 8008,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-38",
    "found-by" : "Methylation_syntax_1a_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-37-13" ],
    "verbose-text" : "PTEN REGULATIONGenetic alteration of PTENPTEN loss of function occurs in a wide spectrum of human cancers through various genetic alterations that include point mutations (missense and nonsense mutations), large chromosomal deletions (homozygous/heterozygous deletions, frameshift deletions, in-frame deletions, and truncations), and epigenetic mechanisms (e.g., hypermethylation of the PTEN promoter region) [21]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-44-116",
    "text" : "PTEN protein expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-44-259"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9251,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9228,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-44",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-19-7" ],
    "verbose-text" : "However, many tumor-derived PTEN mutants retain partial or complete catalytic function, suggesting that alterative mechanisms can lead to PTEN inactivation.Transcriptional regulationIn addition to gene mutations, complete or partial loss of PTEN protein expression may impact PTEN's tumor suppression ability."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-46-108",
    "text" : "PTEN gene expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-46-264"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9419,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9399,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-46",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "Positive regulators of PTEN gene expression include early growth response protein 1, peroxisome proliferator-activated receptor γ (PPARγ) and P53, which have been shown to directly bind to the PTEN promoter region [27–29]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-47-60",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-47-271"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9663,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9648,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-47",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-47-15" ],
    "verbose-text" : "Early growth response protein 1, which regulates PTEN expression during the initial steps of apoptosis, has been shown to directly upregulate the expression of PTEN in non–small cell lung cancer."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-47-36",
    "text" : "Early growth response protein 1, which regulates PTEN expression during the initial steps of apoptosis, has been shown to directly upregulate the expression of PTEN",
    "arguments" : [ {
      "text" : "expression of PTEN",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-47-37"
    }, {
      "text" : "Early growth response protein 1",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-47-38"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9763,
      "object-type" : "relative-pos"
    },
    "trigger" : "upregulate",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9599,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-47",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "Early growth response protein 1, which regulates PTEN expression during the initial steps of apoptosis, has been shown to directly upregulate the expression of PTEN in non–small cell lung cancer."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-47-37",
    "text" : "expression of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-47-37"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9763,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9745,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-47",
    "found-by" : "transcription_1b",
    "verbose-text" : "Early growth response protein 1, which regulates PTEN expression during the initial steps of apoptosis, has been shown to directly upregulate the expression of PTEN in non–small cell lung cancer."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-48-67",
    "text" : "ligand-activated transcription",
    "arguments" : [ {
      "text" : "transcription",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-48-276"
    }, {
      "text" : "ligand",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-48-275"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9836,
      "object-type" : "relative-pos"
    },
    "trigger" : "activated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9806,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-48",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "PPARγ is a ligand-activated transcription factor with anti-inflammatory and anti-tumor effects."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-150",
    "text" : "rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-283"
    }, {
      "text" : "rosiglitazone",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-278"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10079,
      "object-type" : "relative-pos"
    },
    "trigger" : "upregulating",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9931,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-74",
    "text" : "ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-284"
    }, {
      "text" : "ligand",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-277"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10099,
      "object-type" : "relative-pos"
    },
    "trigger" : "leads",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9923,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-84",
    "text" : "rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-283"
    }, {
      "text" : "rosiglitazone",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-278"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10079,
      "object-type" : "relative-pos"
    },
    "trigger" : "leads",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9931,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-101",
    "text" : "rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-284"
    }, {
      "text" : "rosiglitazone",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-278"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10099,
      "object-type" : "relative-pos"
    },
    "trigger" : "inhibiting",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9931,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-102",
    "text" : "ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-284"
    }, {
      "text" : "ligand",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-277"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10099,
      "object-type" : "relative-pos"
    },
    "trigger" : "inhibiting",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9923,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-149",
    "text" : "ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-283"
    }, {
      "text" : "ligand",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-277"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10079,
      "object-type" : "relative-pos"
    },
    "trigger" : "upregulating",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9923,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-73",
    "text" : "rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-284"
    }, {
      "text" : "rosiglitazone",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-278"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10099,
      "object-type" : "relative-pos"
    },
    "trigger" : "leads",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9931,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-49-83",
    "text" : "ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-283"
    }, {
      "text" : "ligand",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-49-277"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10079,
      "object-type" : "relative-pos"
    },
    "trigger" : "leads",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 9923,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-49",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "The activation of its selective ligand, rosiglitazone, leads to the binding of PPARγ at two PTEN promoter sites, PPAR response element 1 and PPAR response element 2, thus upregulating PTEN and inhibiting PI3K activity."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-50-57",
    "text" : "PTEN gene expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-50-285"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10153,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10133,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-50",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-47-15" ],
    "verbose-text" : "Negative regulators of PTEN gene expression include mitogen-activated protein kinase kinase-4, transforming growth factor beta (TGF-β), nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB), IGF-1, the transcriptional cofactor c-Jun proto-oncogene, and the B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) proto-oncogene, which have been shown to suppress PTEN expression in several cancer models [30–32]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-50-40",
    "text" : "transforming growth factor beta (TGF-β), nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB), IGF-1, the transcriptional cofactor c-Jun proto-oncogene, and the B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) proto-oncogene, which have been shown to suppress PTEN expression",
    "arguments" : [ {
      "text" : "PTEN expression",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-50-39"
    }, {
      "text" : "transforming growth factor beta",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-50-41"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "negative-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10523,
      "object-type" : "relative-pos"
    },
    "trigger" : "suppress",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10205,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-50",
    "found-by" : "Negative_regulation_syntax_1_verb",
    "verbose-text" : "Negative regulators of PTEN gene expression include mitogen-activated protein kinase kinase-4, transforming growth factor beta (TGF-β), nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB), IGF-1, the transcriptional cofactor c-Jun proto-oncogene, and the B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) proto-oncogene, which have been shown to suppress PTEN expression in several cancer models [30–32]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-50-39",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-50-39"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10523,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10508,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-50",
    "found-by" : "expression_1",
    "verbose-text" : "Negative regulators of PTEN gene expression include mitogen-activated protein kinase kinase-4, transforming growth factor beta (TGF-β), nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB), IGF-1, the transcriptional cofactor c-Jun proto-oncogene, and the B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) proto-oncogene, which have been shown to suppress PTEN expression in several cancer models [30–32]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-50-38",
    "text" : "TGF-β), nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB), IGF-1, the transcriptional cofactor c-Jun proto-oncogene, and the B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) proto-oncogene, which have been shown to suppress PTEN expression",
    "arguments" : [ {
      "text" : "PTEN expression",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-50-39"
    }, {
      "text" : "TGF-β",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-50-40"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "negative-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10523,
      "object-type" : "relative-pos"
    },
    "trigger" : "suppress",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10238,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-50",
    "found-by" : "Negative_regulation_syntax_1_verb",
    "verbose-text" : "Negative regulators of PTEN gene expression include mitogen-activated protein kinase kinase-4, transforming growth factor beta (TGF-β), nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB), IGF-1, the transcriptional cofactor c-Jun proto-oncogene, and the B-cell-specific Moloney murine leukemia virus insertion site 1 (BMI1) proto-oncogene, which have been shown to suppress PTEN expression in several cancer models [30–32]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-52-114",
    "text" : "TGF-β significantly suppresses PTEN protein levels concomitant with the activation of AKT",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-52-301"
    }, {
      "text" : "TGF-β",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-52-299"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10780,
      "object-type" : "relative-pos"
    },
    "trigger" : "suppresses",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10691,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-52",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "In pancreatic cancers, TGF-β significantly suppresses PTEN protein levels concomitant with the activation of AKT through transcriptional reduction of PTEN mRNA–induced growth promotion."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-52-147",
    "text" : "PTEN protein levels",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-52-300"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10741,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10722,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-52",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-51-16" ],
    "verbose-text" : "In pancreatic cancers, TGF-β significantly suppresses PTEN protein levels concomitant with the activation of AKT through transcriptional reduction of PTEN mRNA–induced growth promotion."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-53-18",
    "text" : "expression of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-53-17"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10903,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10885,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-53",
    "found-by" : "transcription_1b",
    "verbose-text" : "c-Jun negatively regulates the expression of PTEN by binding to the activator protein 1 site of the PTEN promoter, resulting in the concomitant activation of the AKT pathway."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-53-17",
    "text" : "c-Jun negatively regulates the expression of PTEN",
    "arguments" : [ {
      "text" : "expression of PTEN",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-53-18"
    }, {
      "text" : "c-Jun",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-53-18"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "negative-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10903,
      "object-type" : "relative-pos"
    },
    "trigger" : "negatively regulates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 10854,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-53",
    "found-by" : "Negative_regulation_syntax_1_verb",
    "verbose-text" : "c-Jun negatively regulates the expression of PTEN by binding to the activator protein 1 site of the PTEN promoter, resulting in the concomitant activation of the AKT pathway."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-54-52",
    "text" : "PTEN transcription is also directly repressed by the leukemia",
    "arguments" : [ {
      "text" : "PTEN transcription",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-54-53"
    }, {
      "text" : "leukemia",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-54-48"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "negative-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11090,
      "object-type" : "relative-pos"
    },
    "trigger" : "repressed",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11029,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-54",
    "found-by" : "Negative_regulation_syntax_2_verb",
    "verbose-text" : "PTEN transcription is also directly repressed by the leukemia-associated factor ecotropic virus integration site 1 protein in the hematopoietic system [33]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-54-53",
    "text" : "PTEN transcription",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-54-47"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11047,
      "object-type" : "relative-pos"
    },
    "trigger" : "transcription",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11029,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-54",
    "found-by" : "transcription_0",
    "verbose-text" : "PTEN transcription is also directly repressed by the leukemia-associated factor ecotropic virus integration site 1 protein in the hematopoietic system [33]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-56-97",
    "text" : "activated by early growth response protein 1, P53, MYC",
    "arguments" : [ {
      "text" : "MYC",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-314"
    }, {
      "text" : "early growth response protein 1",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-312"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11338,
      "object-type" : "relative-pos"
    },
    "trigger" : "activated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11284,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-56",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "(A) PTEN mRNA transcription is activated by early growth response protein 1, P53, MYC, PPARγ, C-repeat binding factor 1, and others, and inhibited by NF-κB, proto-oncogene c-Jun, TGF-β, and BMI-1."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-56-98",
    "text" : "activated by early growth response protein 1, P53",
    "arguments" : [ {
      "text" : "P53",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-313"
    }, {
      "text" : "early growth response protein 1",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-312"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11333,
      "object-type" : "relative-pos"
    },
    "trigger" : "activated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11284,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-56",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "(A) PTEN mRNA transcription is activated by early growth response protein 1, P53, MYC, PPARγ, C-repeat binding factor 1, and others, and inhibited by NF-κB, proto-oncogene c-Jun, TGF-β, and BMI-1."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-56-95",
    "text" : "activated by early growth response protein 1, P53, MYC, PPAR",
    "arguments" : [ {
      "text" : "PPAR",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-315"
    }, {
      "text" : "early growth response protein 1",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-312"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11344,
      "object-type" : "relative-pos"
    },
    "trigger" : "activated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11284,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-56",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "(A) PTEN mRNA transcription is activated by early growth response protein 1, P53, MYC, PPARγ, C-repeat binding factor 1, and others, and inhibited by NF-κB, proto-oncogene c-Jun, TGF-β, and BMI-1."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-56-96",
    "text" : "activated by early growth response protein 1, P53, MYC, PPARγ, C-repeat binding factor 1",
    "arguments" : [ {
      "text" : "C-repeat binding factor 1",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-316"
    }, {
      "text" : "early growth response protein 1",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-56-312"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11372,
      "object-type" : "relative-pos"
    },
    "trigger" : "activated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11284,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-56",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "(A) PTEN mRNA transcription is activated by early growth response protein 1, P53, MYC, PPARγ, C-repeat binding factor 1, and others, and inhibited by NF-κB, proto-oncogene c-Jun, TGF-β, and BMI-1."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-61-64",
    "text" : "RAS has been found to mediate the suppression of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-61-332"
    }, {
      "text" : "RAS",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-61-331"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12052,
      "object-type" : "relative-pos"
    },
    "trigger" : "mediate",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 11999,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-61",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "For example, RAS has been found to mediate the suppression of PTEN through a TGF-β dependent mechanism in pancreatic cancer [34], and the mitogen-associated protein kinase/extracellular signal-related kinase pathway has been found to suppress PTEN transcription through c-Jun [35]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-61-33",
    "text" : "PTEN transcription",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-61-33"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12247,
      "object-type" : "relative-pos"
    },
    "trigger" : "transcription",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12229,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-61",
    "found-by" : "transcription_0",
    "verbose-text" : "For example, RAS has been found to mediate the suppression of PTEN through a TGF-β dependent mechanism in pancreatic cancer [34], and the mitogen-associated protein kinase/extracellular signal-related kinase pathway has been found to suppress PTEN transcription through c-Jun [35]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-61-32",
    "text" : "extracellular signal-related kinase pathway has been found to suppress PTEN transcription",
    "arguments" : [ {
      "text" : "PTEN transcription",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-61-33"
    }, {
      "text" : "extracellular signal-related kinase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-61-34"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "negative-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12247,
      "object-type" : "relative-pos"
    },
    "trigger" : "suppress",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12158,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-61",
    "found-by" : "Negative_regulation_syntax_1_verb",
    "verbose-text" : "For example, RAS has been found to mediate the suppression of PTEN through a TGF-β dependent mechanism in pancreatic cancer [34], and the mitogen-associated protein kinase/extracellular signal-related kinase pathway has been found to suppress PTEN transcription through c-Jun [35]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-62-13",
    "text" : "stress kinase pathways including mitogen-activated protein kinase kinase kinase 4 and JNK promote resistance to apoptosis by suppressing PTEN transcription",
    "arguments" : [ {
      "text" : "PTEN transcription",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-62-14"
    }, {
      "text" : "stress kinase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-62-14"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12436,
      "object-type" : "relative-pos"
    },
    "trigger" : "promote",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12281,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-62",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "Finally, the stress kinase pathways including mitogen-activated protein kinase kinase kinase 4 and JNK promote resistance to apoptosis by suppressing PTEN transcription via direct binding of NF-κB to the PTEN promoter [36]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-62-14",
    "text" : "PTEN transcription",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-62-13"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12436,
      "object-type" : "relative-pos"
    },
    "trigger" : "transcription",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12418,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-62",
    "found-by" : "transcription_0",
    "verbose-text" : "Finally, the stress kinase pathways including mitogen-activated protein kinase kinase kinase 4 and JNK promote resistance to apoptosis by suppressing PTEN transcription via direct binding of NF-κB to the PTEN promoter [36]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-63-127",
    "text" : "PTEN transcription",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-63-344"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12610,
      "object-type" : "relative-pos"
    },
    "trigger" : "transcription",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12592,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-63",
    "found-by" : "transcription_0",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-58-19" ],
    "verbose-text" : "These findings suggest that the pathways that are negatively regulated by PTEN can in turn regulate PTEN transcription, indicating a potential feedback loop."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-64-124",
    "text" : "PTEN transcription",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-64-347"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12771,
      "object-type" : "relative-pos"
    },
    "trigger" : "transcription",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12753,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-64",
    "found-by" : "transcription_0",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-64-20" ],
    "verbose-text" : "Studies have also shown that CpG islands hypermethylated in the PTEN promoter lead to the silencing of PTEN transcription in human cancer [37]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-64-122",
    "text" : "hypermethylated in the PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-64-346"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "methylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12718,
      "object-type" : "relative-pos"
    },
    "trigger" : "hypermethylated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 12691,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-64",
    "found-by" : "Methylation_syntax_1b_verb",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-64-20" ],
    "verbose-text" : "Studies have also shown that CpG islands hypermethylated in the PTEN promoter lead to the silencing of PTEN transcription in human cancer [37]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-66-119",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-66-352"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13059,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13044,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-66",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-19-7" ],
    "verbose-text" : "Various miRNAs are known to impact PTEN expression in both normal and pathological conditions."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-67-113",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-67-355"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13245,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13230,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-67",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-19-7" ],
    "verbose-text" : "In multiple human cancers, PTEN expressions are downregulated by miRNAs, which are shown in Table 1.MiRNAs which downregulate PTEN expression in human cancersPost-translational modifications, such as active site phosphorylation, ubiquitination, oxidation, and acetylation, can also regulate PTEN activity [39]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-67-63",
    "text" : "PTEN expressions",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-67-354"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13147,
      "object-type" : "relative-pos"
    },
    "trigger" : "expressions",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13131,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-67",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-19-7" ],
    "verbose-text" : "In multiple human cancers, PTEN expressions are downregulated by miRNAs, which are shown in Table 1.MiRNAs which downregulate PTEN expression in human cancersPost-translational modifications, such as active site phosphorylation, ubiquitination, oxidation, and acetylation, can also regulate PTEN activity [39]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-70-131",
    "text" : "phosphorylation of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-70-368"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13793,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 13770,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-70",
    "found-by" : "Phosphorylation_token_of",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-70-21" ],
    "verbose-text" : "The phosphorylation of PTEN at specific residues of the C-terminal tail (Thr366, Ser370, Ser380, Thr382, Thr383, and Ser385) is associated with increased protein stability, whereas phosphorylation at other sites may decrease protein stability."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-71-100",
    "text" : "PTEN phosphorylation",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-71-378"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14097,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14077,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-71",
    "found-by" : "Phosphorylation_syntax_4_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-71-22" ],
    "verbose-text" : "Although S370 and S385 have been identified as the major sites for PTEN phosphorylation, mutations of these residues have minimal effects on PTEN function, whereas mutations of S380, T382, and T383 can destabilize PTEN and increase its phosphatase activity, thereby enhancing PTEN's interaction with binding partners [40]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-72-69",
    "text" : "ubiquitin-mediated proteasome degradation",
    "arguments" : [ {
      "text" : "ubiquitin",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-72-387"
    }, {
      "text" : "proteasome degradation",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-72-388"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14422,
      "object-type" : "relative-pos"
    },
    "trigger" : "mediated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14381,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-72",
    "found-by" : "Positive_early_activation",
    "verbose-text" : "The “open” state of PTEN is more susceptible to ubiquitin-mediated proteasome degradation [13]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-74-16",
    "text" : "PTEN levels",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-74-15"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14808,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14797,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-74",
    "found-by" : "amount_1",
    "verbose-text" : "In cancer, the inhibition of NEDD4-1, whose expression has been found to be inversely correlated with PTEN levels in bladder cancer, may upregulate PTEN levels [42]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-74-140",
    "text" : "PTEN levels",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-74-396"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14762,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14751,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-74",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-74-24" ],
    "verbose-text" : "In cancer, the inhibition of NEDD4-1, whose expression has been found to be inversely correlated with PTEN levels in bladder cancer, may upregulate PTEN levels [42]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-74-15",
    "text" : "NEDD4-1, whose expression has been found to be inversely correlated with PTEN levels in bladder cancer, may upregulate PTEN levels",
    "arguments" : [ {
      "text" : "PTEN levels",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-74-16"
    }, {
      "text" : "NEDD4-1",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-74-16"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "negative-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14808,
      "object-type" : "relative-pos"
    },
    "trigger" : "upregulate",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 14678,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-74",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "In cancer, the inhibition of NEDD4-1, whose expression has been found to be inversely correlated with PTEN levels in bladder cancer, may upregulate PTEN levels [42]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-77-129",
    "text" : "AKT activation, which enhances cell growth",
    "arguments" : [ {
      "text" : "cell growth",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-77-411"
    }, {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-77-410"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15280,
      "object-type" : "relative-pos"
    },
    "trigger" : "enhances",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15238,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-77",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "PI3K activation converts PIP2 to PIP3, thereby leading to AKT activation, which enhances cell growth, proliferation, and survival."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-77-128",
    "text" : "AKT activation, which enhances cell growth, proliferation",
    "arguments" : [ {
      "text" : "proliferation",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-77-412"
    }, {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-77-410"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15295,
      "object-type" : "relative-pos"
    },
    "trigger" : "enhances",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15238,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-77",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "PI3K activation converts PIP2 to PIP3, thereby leading to AKT activation, which enhances cell growth, proliferation, and survival."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-78-70",
    "text" : "PIP3 and consequently suppresses the PI3K",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-78-413"
    }, {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-78-28"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15374,
      "object-type" : "relative-pos"
    },
    "trigger" : "suppresses",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15333,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-78",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "PTEN dephosphorylates PIP3 and consequently suppresses the PI3K pathway."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-78-29",
    "text" : "dephosphorylates PIP3",
    "arguments" : [ {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-78-28"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "dephosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15337,
      "object-type" : "relative-pos"
    },
    "trigger" : "dephosphorylates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15316,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-78",
    "found-by" : "Dephosphorylation_syntax_1a_verb",
    "verbose-text" : "PTEN dephosphorylates PIP3 and consequently suppresses the PI3K pathway."
  }, {
    "text" : "PTEN dephosphorylates PIP3",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-78-28",
    "arguments" : [ {
      "text" : "dephosphorylates PIP3",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-78-29"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-78-29"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15337,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15311,
      "object-type" : "relative-pos"
    },
    "found-by" : "Dephosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-78",
    "verbose-text" : "PTEN dephosphorylates PIP3 and consequently suppresses the PI3K pathway."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-79-44",
    "text" : "E3 ligase of PTEN that mediates PTEN ubiquitination",
    "arguments" : [ {
      "text" : "PTEN ubiquitination",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-79-45"
    }, {
      "text" : "E3",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-79-44"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15449,
      "object-type" : "relative-pos"
    },
    "trigger" : "mediates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15398,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-79",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "NEDD4-1 is an E3 ligase of PTEN that mediates PTEN ubiquitination."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-79-46",
    "text" : "PTEN that mediates PTEN ubiquitination",
    "arguments" : [ {
      "text" : "PTEN ubiquitination",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-79-45"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-79-45"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15449,
      "object-type" : "relative-pos"
    },
    "trigger" : "mediates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15411,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-79",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "NEDD4-1 is an E3 ligase of PTEN that mediates PTEN ubiquitination."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-79-45",
    "text" : "PTEN ubiquitination",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-79-43"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "ubiquitination",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15449,
      "object-type" : "relative-pos"
    },
    "trigger" : "ubiquitination",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15430,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-79",
    "found-by" : "Ubiquitination_syntax_4_noun",
    "verbose-text" : "NEDD4-1 is an E3 ligase of PTEN that mediates PTEN ubiquitination."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-80-161",
    "text" : "Polyubiquitination of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-80-415"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "ubiquitination",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15477,
      "object-type" : "relative-pos"
    },
    "trigger" : "Polyubiquitination",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15451,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-80",
    "found-by" : "Ubiquitination_syntax_1a_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-80-27" ],
    "verbose-text" : "Polyubiquitination of PTEN leads to its degradation in the plasma, whereas monoubiquitination of PTEN increases its nuclear localization."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-80-160",
    "text" : "PTEN leads to its degradation in the plasma, whereas monoubiquitination of PTEN increases its nuclear localization",
    "arguments" : [ {
      "text" : "localization",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-80-418"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-80-415"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15587,
      "object-type" : "relative-pos"
    },
    "trigger" : "leads",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15473,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-80",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Polyubiquitination of PTEN leads to its degradation in the plasma, whereas monoubiquitination of PTEN increases its nuclear localization."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-80-77",
    "text" : "PTEN increases its nuclear localization",
    "arguments" : [ {
      "text" : "localization",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-80-418"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-80-417"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15587,
      "object-type" : "relative-pos"
    },
    "trigger" : "increases",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15548,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-80",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Polyubiquitination of PTEN leads to its degradation in the plasma, whereas monoubiquitination of PTEN increases its nuclear localization."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-80-137",
    "text" : "monoubiquitination of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-80-417"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "ubiquitination",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15552,
      "object-type" : "relative-pos"
    },
    "trigger" : "monoubiquitination",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15526,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-80",
    "found-by" : "Ubiquitination_syntax_1a_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-80-27" ],
    "verbose-text" : "Polyubiquitination of PTEN leads to its degradation in the plasma, whereas monoubiquitination of PTEN increases its nuclear localization."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-81-120",
    "text" : "PTEN can translocate into the nucleus",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-81-419"
    }, {
      "text" : "nucleus",
      "argument-type" : "entity",
      "type" : "destination",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-81-420"
    } ],
    "type" : "translocation",
    "frame-type" : "event-mention",
    "subtype" : "translocation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15626,
      "object-type" : "relative-pos"
    },
    "trigger" : "translocate",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15589,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-81",
    "found-by" : "translocation_8b_verb_active_no_cause",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-80-27" ],
    "verbose-text" : "PTEN can translocate into the nucleus through various mechanisms, including passive diffusion, Ran- or major vault protein–mediated import, and a monoubiquitination-driven mechanism."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-10",
    "text" : "P53 acetylation",
    "arguments" : [ {
      "text" : "P53",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-82-10"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "acetylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15831,
      "object-type" : "relative-pos"
    },
    "trigger" : "acetylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15816,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-82",
    "found-by" : "Acetylation_syntax_4_noun",
    "verbose-text" : "In the nucleus, PTEN promotes p300-mediated P53 acetylation in response to DNA damage to control cellular proliferation."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-48",
    "text" : "p300-mediated P53 acetylation",
    "arguments" : [ {
      "text" : "p300",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-82-9"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "acetylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15831,
      "object-type" : "relative-pos"
    },
    "trigger" : "acetylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15802,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-82",
    "found-by" : "Acetylation_syntax_4_noun",
    "verbose-text" : "In the nucleus, PTEN promotes p300-mediated P53 acetylation in response to DNA damage to control cellular proliferation."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-22",
    "text" : "PTEN promotes p300-mediated P53 acetylation",
    "arguments" : [ {
      "text" : "p300-mediated P53 acetylation",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-9"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-82-22"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15831,
      "object-type" : "relative-pos"
    },
    "trigger" : "promotes",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15788,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-82",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "In the nucleus, PTEN promotes p300-mediated P53 acetylation in response to DNA damage to control cellular proliferation."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-9",
    "text" : "p300-mediated P53 acetylation",
    "arguments" : [ {
      "text" : "p300",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-82-9"
    }, {
      "text" : "P53 acetylation",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-10"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15831,
      "object-type" : "relative-pos"
    },
    "trigger" : "mediated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15802,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-82",
    "found-by" : "Positive_early_regulation",
    "verbose-text" : "In the nucleus, PTEN promotes p300-mediated P53 acetylation in response to DNA damage to control cellular proliferation."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-47",
    "text" : "PTEN promotes p300-mediated P53 acetylation",
    "arguments" : [ {
      "text" : "p300-mediated P53 acetylation",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-82-48"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-82-22"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15831,
      "object-type" : "relative-pos"
    },
    "trigger" : "promotes",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 15788,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-82",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "In the nucleus, PTEN promotes p300-mediated P53 acetylation in response to DNA damage to control cellular proliferation."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-86-126",
    "text" : "PTEN protein levels",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-86-439"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16435,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16416,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-86",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-86-29" ],
    "verbose-text" : "A number of PTEN-interacting proteins have been shown to regulate PTEN protein levels and activities."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-87-144",
    "text" : "phosphorylation of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-87-442"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16571,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16548,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-87",
    "found-by" : "Phosphorylation_token_of",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-86-29" ],
    "verbose-text" : "These interactions, which help recruit PTEN to the membrane, can be negatively modulated by the phosphorylation of PTEN on its C terminus [40, 45]."
  }, {
    "text" : "C2 domain of PTEN can be phosphorylated by RhoA",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-89-30",
    "arguments" : [ {
      "text" : "C2 domain of PTEN can be phosphorylated",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-89-31"
    }, {
      "text" : "RhoA",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-89-32"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16836,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16789,
      "object-type" : "relative-pos"
    },
    "found-by" : "Phosphorylation_syntax_2a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-89",
    "verbose-text" : "In addition, evidence suggests that the C2 domain of PTEN can be phosphorylated by RhoA-associated kinase, which may have important roles in the regulation of chemoattractant-induced PTEN localization [48] (Figure 2)."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-89-31",
    "text" : "C2 domain of PTEN can be phosphorylated",
    "arguments" : [ {
      "text" : "C2 domain",
      "argument-type" : "entity",
      "type" : "site",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-89-30"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-89-31"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16828,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 16789,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-89",
    "found-by" : "Phosphorylation_syntax_2a_verb",
    "verbose-text" : "In addition, evidence suggests that the C2 domain of PTEN can be phosphorylated by RhoA-associated kinase, which may have important roles in the regulation of chemoattractant-induced PTEN localization [48] (Figure 2)."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-133",
    "text" : "cAMP response element-binding protein (CREB)-binding protein (CBP",
    "arguments" : [ {
      "text" : "CBP",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-453"
    }, {
      "text" : "cAMP",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 1,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-451"
    } ],
    "type" : "complex-assembly",
    "frame-type" : "event-mention",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17176,
      "object-type" : "relative-pos"
    },
    "trigger" : "binding",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17111,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "found-by" : "binding5",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-132",
    "text" : "cAMP response element-binding protein (CREB",
    "arguments" : [ {
      "text" : "cAMP",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-451"
    }, {
      "text" : "CREB",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 1,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-452"
    } ],
    "type" : "complex-assembly",
    "frame-type" : "event-mention",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17154,
      "object-type" : "relative-pos"
    },
    "trigger" : "binding",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17111,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "found-by" : "binding5",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-76",
    "text" : "acetylation negatively regulates the catalytic activity of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-454"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "acetylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17298,
      "object-type" : "relative-pos"
    },
    "trigger" : "acetylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17235,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "found-by" : "Acetylation_syntax_7_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-134",
    "text" : "binding protein (CREB)-binding protein (CBP",
    "arguments" : [ {
      "text" : "CBP",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-453"
    }, {
      "text" : "CREB",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 1,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-452"
    } ],
    "type" : "complex-assembly",
    "frame-type" : "event-mention",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17176,
      "object-type" : "relative-pos"
    },
    "trigger" : "binding",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17133,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "found-by" : "binding5",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-6",
    "text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation",
    "arguments" : [ {
      "text" : "PTEN acetylation",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-7"
    }, {
      "text" : "PTEN's interaction with nuclear histone",
      "argument-type" : "complex",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "args" : {
        "theme1" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-7",
        "theme2" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-8"
      }
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17224,
      "object-type" : "relative-pos"
    },
    "trigger" : "promote",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17037,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "found-by" : "Positive_regulation_syntax_1_verb",
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-159",
    "text" : "PTEN's interaction with nuclear histone",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-7"
    }, {
      "text" : "histone",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 1,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-8"
    } ],
    "type" : "complex-assembly",
    "frame-type" : "event-mention",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17076,
      "object-type" : "relative-pos"
    },
    "trigger" : "interaction",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17037,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "found-by" : "binding_syntax_24_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "text" : "PTEN's interaction with nuclear histone",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-8",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-7"
    }, {
      "text" : "histone",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 1,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-8"
    } ],
    "type" : "complex-assembly",
    "frame-type" : "event-mention",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17076,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17037,
      "object-type" : "relative-pos"
    },
    "found-by" : "binding_syntax_24_noun",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-91-7",
    "text" : "PTEN acetylation",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-91-6"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "acetylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17224,
      "object-type" : "relative-pos"
    },
    "trigger" : "acetylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17208,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-91",
    "found-by" : "Acetylation_syntax_4_noun",
    "verbose-text" : "PTEN's interaction with nuclear histone acetyltransferase–associated p300/cAMP response element-binding protein (CREB)-binding protein (CBP)–associated factor can promote PTEN acetylation, and this acetylation negatively regulates the catalytic activity of PTEN [49]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-92-87",
    "text" : "reactive oxygen species (ROS) stimulated by growth factors and insulin",
    "arguments" : [ {
      "text" : "reactive oxygen species",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-92-456"
    }, {
      "text" : "insulin",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-92-458"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17481,
      "object-type" : "relative-pos"
    },
    "trigger" : "stimulated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17411,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-92",
    "found-by" : "Positive_activation_syntax_2_verb",
    "verbose-text" : "Studies have shown that the PTEN protein becomes oxidized in response to the endogenous generation of the reactive oxygen species (ROS) stimulated by growth factors and insulin, and this oxidation correlates with a ROS-dependent activation of downstream AKT phosphorylation [50, 51]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-92-1",
    "text" : "ROS-dependent activation of downstream AKT phosphorylation",
    "arguments" : [ {
      "text" : "AKT phosphorylation",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-92-2"
    }, {
      "text" : "ROS",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-92-2"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17578,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17520,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-92",
    "found-by" : "Positive_regulation_syntax_3_noun",
    "verbose-text" : "Studies have shown that the PTEN protein becomes oxidized in response to the endogenous generation of the reactive oxygen species (ROS) stimulated by growth factors and insulin, and this oxidation correlates with a ROS-dependent activation of downstream AKT phosphorylation [50, 51]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-92-86",
    "text" : "ROS) stimulated by growth factors and insulin",
    "arguments" : [ {
      "text" : "ROS",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-92-457"
    }, {
      "text" : "insulin",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-92-458"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17481,
      "object-type" : "relative-pos"
    },
    "trigger" : "stimulated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17436,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-92",
    "found-by" : "Positive_activation_syntax_2_verb",
    "verbose-text" : "Studies have shown that the PTEN protein becomes oxidized in response to the endogenous generation of the reactive oxygen species (ROS) stimulated by growth factors and insulin, and this oxidation correlates with a ROS-dependent activation of downstream AKT phosphorylation [50, 51]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-92-2",
    "text" : "AKT phosphorylation",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-92-1"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17578,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17559,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-92",
    "found-by" : "Phosphorylation_syntax_4_noun",
    "verbose-text" : "Studies have shown that the PTEN protein becomes oxidized in response to the endogenous generation of the reactive oxygen species (ROS) stimulated by growth factors and insulin, and this oxidation correlates with a ROS-dependent activation of downstream AKT phosphorylation [50, 51]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-94-75",
    "text" : "P53 expression",
    "arguments" : [ {
      "text" : "P53",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-94-464"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17804,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17790,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-94",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-93-31" ],
    "verbose-text" : "High P53 expression triggers proteasome degradation of the PTEN protein [54]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-94-104",
    "text" : "P53 expression triggers proteasome degradation",
    "arguments" : [ {
      "text" : "proteasome degradation",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-94-465"
    }, {
      "text" : "P53",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-94-464"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17836,
      "object-type" : "relative-pos"
    },
    "trigger" : "triggers",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17790,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-94",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "High P53 expression triggers proteasome degradation of the PTEN protein [54]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-94-103",
    "text" : "P53 expression triggers proteasome degradation of the PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-94-466"
    }, {
      "text" : "P53",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-94-464"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17848,
      "object-type" : "relative-pos"
    },
    "trigger" : "triggers",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17790,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-94",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "High P53 expression triggers proteasome degradation of the PTEN protein [54]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-95-153",
    "text" : "antagonizing the AKT–mouse double minute 2 homolog pathway in a phosphatase-dependent manner, PTEN also can interact with P53",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-95-467"
    }, {
      "text" : "P53",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-95-471"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 18003,
      "object-type" : "relative-pos"
    },
    "trigger" : "antagonizing",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17878,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-95",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "In addition to antagonizing the AKT–mouse double minute 2 homolog pathway in a phosphatase-dependent manner, PTEN also can interact with P53 directly in a phosphatase-independent manner, thereby stabilizing P53 [55, 56]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-95-152",
    "text" : "antagonizing the AKT–mouse double minute 2 homolog pathway in a phosphatase-dependent manner, PTEN also can interact with P53 directly in a phosphatase",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-95-467"
    }, {
      "text" : "phosphatase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-95-472"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 18029,
      "object-type" : "relative-pos"
    },
    "trigger" : "antagonizing",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 17878,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-95",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "In addition to antagonizing the AKT–mouse double minute 2 homolog pathway in a phosphatase-dependent manner, PTEN also can interact with P53 directly in a phosphatase-independent manner, thereby stabilizing P53 [55, 56]."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-96-78",
    "text" : "translocation of PTEN from the nucleus to the cytoplasm",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-96-475"
    }, {
      "text" : "cytoplasm",
      "argument-type" : "entity",
      "type" : "destination",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-96-477"
    }, {
      "text" : "nucleus",
      "argument-type" : "entity",
      "type" : "source",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-96-476"
    } ],
    "type" : "translocation",
    "frame-type" : "event-mention",
    "subtype" : "translocation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 18192,
      "object-type" : "relative-pos"
    },
    "trigger" : "translocation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 18137,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-96",
    "found-by" : "translocation_4a_noun_with_cause",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-95-32" ],
    "verbose-text" : "PTEN IN THE NUCLEUSGrowing evidence suggests that the translocation of PTEN from the nucleus to the cytoplasm leads to malignancy."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-99-123",
    "text" : "levels of nuclear PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-99-491"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 18751,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 18729,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-99",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-99-33" ],
    "verbose-text" : "High expression levels of nuclear PTEN have been associated with cell-cycle arrest at the G0/G1 phase, indicating a role of nuclear PTEN in cell growth inhibition [62]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-103-92",
    "text" : "PTEN is preferentially expressed",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-103-506"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 19528,
      "object-type" : "relative-pos"
    },
    "trigger" : "expressed",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 19496,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-103",
    "found-by" : "expression_3",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-102-35" ],
    "verbose-text" : "Thus, PTEN is preferentially expressed in the cytoplasm of tumor cells in which PI3K signaling is frequently activated."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-109-158",
    "text" : "p53 acetylation",
    "arguments" : [ {
      "text" : "p53",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-109-530"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "acetylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 20345,
      "object-type" : "relative-pos"
    },
    "trigger" : "acetylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 20330,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-109",
    "found-by" : "Acetylation_syntax_4_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-108-40" ],
    "verbose-text" : "Moreover, nuclear PTEN has been shown to promote p300/CREB-binding protein–mediated p53 acetylation in the response to DNA damage [69, 70]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-111-155",
    "text" : "PTEN but also activated PI3K",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-111-537"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-111-536"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 20545,
      "object-type" : "relative-pos"
    },
    "trigger" : "activated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 20517,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-111",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Not only PTEN but also activated PI3K and functional PIP3 have been detected in the nucleus [71], indicating that nuclear PI3K signaling mediates PTEN's antiapoptotic effect through nuclear PIP3 and nuclear AKT."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-111-154",
    "text" : "PTEN but also activated PI3K and functional PIP3",
    "arguments" : [ {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-111-538"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-111-536"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 20565,
      "object-type" : "relative-pos"
    },
    "trigger" : "activated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 20517,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-111",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Not only PTEN but also activated PI3K and functional PIP3 have been detected in the nucleus [71], indicating that nuclear PI3K signaling mediates PTEN's antiapoptotic effect through nuclear PIP3 and nuclear AKT."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-115-72",
    "text" : "NOTCH1 signaling in T-ALL",
    "arguments" : [ {
      "text" : "T-ALL",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-115-561"
    }, {
      "text" : "NOTCH1",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-115-560"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 21368,
      "object-type" : "relative-pos"
    },
    "trigger" : "signaling",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 21343,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-115",
    "found-by" : "Positive_activation_syntax_3_noun",
    "verbose-text" : "Moreover, PTEN mutations have been shown induced resistance to γ-secretase inhibitors, which derepress the constitutively activated NOTCH1 signaling in T-ALL [77]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-125-91",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-125-591"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23046,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23031,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-125",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "In the GCB-DLBCL cell lines, PTEN loss was inversely correlated with the constitutive activation of the PI3K/AKT signaling pathway, whereas GCB-DLBCL cell lines with PTEN expression rarely had PI3K/AKT activation."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-126-80",
    "text" : "AKT activation regardless of PTEN status, which suggests that the activation of PI3K",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-595"
    }, {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-597"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23210,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23126,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-126",
    "found-by" : "Positive_activation_syntax_7_noun",
    "verbose-text" : "In contrast, all ABC-DLBCL cell lines had PI3K/AKT activation regardless of PTEN status, which suggests that the activation of PI3K/AKT in GCB-DLBCL results from PTEN deficiency."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-126-81",
    "text" : "PI3K/AKT activation regardless of PTEN status, which suggests that the activation of PI3K/AKT",
    "arguments" : [ {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-594"
    }, {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-598"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23214,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23121,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-126",
    "found-by" : "Positive_activation_syntax_7_noun",
    "verbose-text" : "In contrast, all ABC-DLBCL cell lines had PI3K/AKT activation regardless of PTEN status, which suggests that the activation of PI3K/AKT in GCB-DLBCL results from PTEN deficiency."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-126-65",
    "text" : "PI3K/AKT activation regardless of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-596"
    }, {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-594"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23159,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23121,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-126",
    "found-by" : "Positive_activation_syntax_3_noun",
    "verbose-text" : "In contrast, all ABC-DLBCL cell lines had PI3K/AKT activation regardless of PTEN status, which suggests that the activation of PI3K/AKT in GCB-DLBCL results from PTEN deficiency."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-126-66",
    "text" : "AKT activation regardless of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-596"
    }, {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-126-595"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23159,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23126,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-126",
    "found-by" : "Positive_activation_syntax_3_noun",
    "verbose-text" : "In contrast, all ABC-DLBCL cell lines had PI3K/AKT activation regardless of PTEN status, which suggests that the activation of PI3K/AKT in GCB-DLBCL results from PTEN deficiency."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-128-93",
    "text" : "PTEN re-expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-128-36"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23447,
      "object-type" : "relative-pos"
    },
    "trigger" : "re-expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23429,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-128",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "Also, inhibition of PI3K/AKT with either PTEN re-expression or PI3K inhibition significantly downregulated MYC expression, suggesting that PTEN loss leads to the upregulation of MYC through the constitutive activation of PI3K/AKT in DLBCL [85]."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-128-34",
    "text" : "PTEN re-expression or PI3K inhibition significantly downregulated MYC expression",
    "arguments" : [ {
      "text" : "MYC expression",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-128-35"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-128-36"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23509,
      "object-type" : "relative-pos"
    },
    "trigger" : "downregulated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23429,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-128",
    "found-by" : "Negative_regulation_syntax_1_verb",
    "verbose-text" : "Also, inhibition of PI3K/AKT with either PTEN re-expression or PI3K inhibition significantly downregulated MYC expression, suggesting that PTEN loss leads to the upregulation of MYC through the constitutive activation of PI3K/AKT in DLBCL [85]."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-128-79",
    "text" : "PTEN re-expression or PI3K inhibition significantly downregulated MYC expression, suggesting that PTEN loss leads to the upregulation of MYC",
    "arguments" : [ {
      "text" : "MYC",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-128-606"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-128-36"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23569,
      "object-type" : "relative-pos"
    },
    "trigger" : "downregulated",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23429,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-128",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "Also, inhibition of PI3K/AKT with either PTEN re-expression or PI3K inhibition significantly downregulated MYC expression, suggesting that PTEN loss leads to the upregulation of MYC through the constitutive activation of PI3K/AKT in DLBCL [85]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-128-35",
    "text" : "MYC expression",
    "arguments" : [ {
      "text" : "MYC",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-128-35"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23509,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 23495,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-128",
    "found-by" : "expression_1",
    "verbose-text" : "Also, inhibition of PI3K/AKT with either PTEN re-expression or PI3K inhibition significantly downregulated MYC expression, suggesting that PTEN loss leads to the upregulation of MYC through the constitutive activation of PI3K/AKT in DLBCL [85]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-130-163",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-130-614"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24161,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24146,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-130",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "Fridberg et al. found a trend towards a stronger staining intensity of cytoplasmic and nuclear PTEN in 28 non–GCB-DLBCL patients [59], most importantly, they found that the absence of nuclear PTEN expression was correlated with worse survival."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-131-125",
    "text" : "expression of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-131-618"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24517,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24499,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-131",
    "found-by" : "transcription_3",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "This interesting evidence should be corroborated in a larger number of primary samples in further studies.PTEN deficiency in other lymphomasPrevious studies of mantle cell lymphoma (MCL) showed that although the disease had no detectable genetic alterations of PTEN, it did have extremely low protein expression of PTEN."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-132-58",
    "text" : "pAKT and PTEN expression",
    "arguments" : [ {
      "text" : "pAKT",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-132-623"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24664,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24640,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-132",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "To determine whether the PI3K/AKT signaling pathway is involved in the pathogenesis of MCL, Rudelius et al. investigated pAKT and PTEN expression in primary MCL specimens and cell lines."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-132-59",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-132-624"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24664,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24649,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-132",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "To determine whether the PI3K/AKT signaling pathway is involved in the pathogenesis of MCL, Rudelius et al. investigated pAKT and PTEN expression in primary MCL specimens and cell lines."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-133-130",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-133-627"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24771,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24756,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-133",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "Of the 31 MCL specimens, 6 had markedly decreased PTEN expression; of the 4 MCL cell lines, 3 had complete loss of PTEN expression [86]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-133-99",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-133-629"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24836,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24821,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-133",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "Of the 31 MCL specimens, 6 had markedly decreased PTEN expression; of the 4 MCL cell lines, 3 had complete loss of PTEN expression [86]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-134-71",
    "text" : "loss of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-134-632"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "decreaseamount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 25000,
      "object-type" : "relative-pos"
    },
    "trigger" : "loss",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 24988,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-134",
    "found-by" : "decrease_amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "The authors found no phosphatidyl inositol 3-kinase catalytic subunit (PIK3CA) mutations in the primary specimens or cell lines, suggesting that loss of PTEN activates the PI3K/AKT pathway in MCL.Loss of PTEN protein expression has also been reported in 32% of patients with primary cutaneous DLBCL–leg type and 27% of patients with primary cutaneous follicle center lymphomas."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-134-141",
    "text" : "PTEN protein expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-134-635"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 25070,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 25047,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-134",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "The authors found no phosphatidyl inositol 3-kinase catalytic subunit (PIK3CA) mutations in the primary specimens or cell lines, suggesting that loss of PTEN activates the PI3K/AKT pathway in MCL.Loss of PTEN protein expression has also been reported in 32% of patients with primary cutaneous DLBCL–leg type and 27% of patients with primary cutaneous follicle center lymphomas."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-136-56",
    "text" : "PTEN mRNA levels",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-136-640"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 25373,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 25357,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-136",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-131-44" ],
    "verbose-text" : "Moreover, low PTEN mRNA levels were significantly associated with shorter disease-free survival [87]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-142-157",
    "text" : "loss of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-142-658"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "decreaseamount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26094,
      "object-type" : "relative-pos"
    },
    "trigger" : "loss",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26082,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-142",
    "found-by" : "decrease_amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "In their study of 215 DLBCL patients, Abubaker et al. reported that 8% had PIK3CA mutations and 37% had loss of PTEN."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-144-121",
    "text" : "PTEN expression",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-144-662"
    } ],
    "type" : "transcription",
    "frame-type" : "event-mention",
    "subtype" : "transcription",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26281,
      "object-type" : "relative-pos"
    },
    "trigger" : "expression",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26266,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-144",
    "found-by" : "expression_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "However, correlation analysis revealed that most of the PIK3CA mutations occurred in cases with PTEN expression (P=0.0146)."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-146-143",
    "text" : "activation independently of PTEN deficiency.Both p110α and p110",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-146-669"
    }, {
      "text" : "p110",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-146-671"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26598,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26535,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-146",
    "found-by" : "Positive_activation_syntax_3_noun",
    "verbose-text" : "This suggests that PIK3CA mutation likely functions as an oncogene in DLBCL by contributing to PI3K pathway activation independently of PTEN deficiency.Both p110α and p110β may generate distinct pools of PIP3."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-146-164",
    "text" : "PI3K pathway activation independently of PTEN deficiency.Both p110",
    "arguments" : [ {
      "text" : "p110",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-146-670"
    }, {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-146-668"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26588,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26522,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-146",
    "found-by" : "Positive_activation_syntax_3_noun",
    "verbose-text" : "This suggests that PIK3CA mutation likely functions as an oncogene in DLBCL by contributing to PI3K pathway activation independently of PTEN deficiency.Both p110α and p110β may generate distinct pools of PIP3."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-146-142",
    "text" : "PI3K pathway activation independently of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-146-669"
    }, {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-146-668"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26567,
      "object-type" : "relative-pos"
    },
    "trigger" : "activation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26522,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-146",
    "found-by" : "Positive_activation_syntax_3_noun",
    "verbose-text" : "This suggests that PIK3CA mutation likely functions as an oncogene in DLBCL by contributing to PI3K pathway activation independently of PTEN deficiency.Both p110α and p110β may generate distinct pools of PIP3."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-147-62",
    "text" : "AKT phosphorylation",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-147-675"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26750,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26731,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-147",
    "found-by" : "Phosphorylation_syntax_4_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "In response to stimuli, p110α produces an acute flux of PIP3, which is efficiently coupled to AKT phosphorylation."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-147-82",
    "text" : "p110α produces an acute flux of PIP3",
    "arguments" : [ {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-147-674"
    }, {
      "text" : "p110",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-147-673"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26697,
      "object-type" : "relative-pos"
    },
    "trigger" : "produces",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26661,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-147",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "In response to stimuli, p110α produces an acute flux of PIP3, which is efficiently coupled to AKT phosphorylation."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-148-146",
    "text" : "AKT phosphorylation",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-148-678"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26864,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26845,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-148",
    "found-by" : "Phosphorylation_syntax_4_noun",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "In contrast, p110β has been proposed to generate a basal level of PIP3 with little effect on AKT phosphorylation [90]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-148-145",
    "text" : "level of PIP3",
    "arguments" : [ {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-148-677"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26822,
      "object-type" : "relative-pos"
    },
    "trigger" : "level",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26809,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-148",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "In contrast, p110β has been proposed to generate a basal level of PIP3 with little effect on AKT phosphorylation [90]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-149-24",
    "text" : "AKT phosphorylation",
    "arguments" : [ {
      "text" : "AKT",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-149-23"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26911,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylation",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26892,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-149",
    "found-by" : "Phosphorylation_syntax_4_noun",
    "verbose-text" : "Moreover, cells with AKT phosphorylation induced by PTEN loss were sensitive to a p110β-specific inhibitor but not a p110α inhibitor both in vitro and in vivo [91, 92], which suggests that the enhancement of basal PIP3 drive oncogenesis in the absence of PTEN."
  }, {
    "is-hypothesis" : true,
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-149-117",
    "text" : "PIP3 drive oncogenesis",
    "arguments" : [ {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-149-681"
    }, {
      "text" : "oncogenesis",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-149-682"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 27107,
      "object-type" : "relative-pos"
    },
    "trigger" : "drive",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 27085,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-149",
    "found-by" : "Positive_activation_token_1_noun",
    "verbose-text" : "Moreover, cells with AKT phosphorylation induced by PTEN loss were sensitive to a p110β-specific inhibitor but not a p110α inhibitor both in vitro and in vivo [91, 92], which suggests that the enhancement of basal PIP3 drive oncogenesis in the absence of PTEN."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-149-23",
    "text" : "AKT phosphorylation induced by PTEN",
    "arguments" : [ {
      "text" : "AKT phosphorylation",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-149-24"
    }, {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-149-24"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "negative-regulation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26927,
      "object-type" : "relative-pos"
    },
    "trigger" : "induced",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 26892,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-149",
    "found-by" : "Positive_regulation_syntax_2_verb",
    "verbose-text" : "Moreover, cells with AKT phosphorylation induced by PTEN loss were sensitive to a p110β-specific inhibitor but not a p110α inhibitor both in vitro and in vivo [91, 92], which suggests that the enhancement of basal PIP3 drive oncogenesis in the absence of PTEN."
  }, {
    "text" : "SRC family kinase LYN phosphorylates the transmembrane protein",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-155-19",
    "arguments" : [ {
      "text" : "phosphorylates the transmembrane protein",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-155-20"
    }, {
      "text" : "SRC family kinase",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-155-20"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28100,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28038,
      "object-type" : "relative-pos"
    },
    "found-by" : "Phosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-155",
    "verbose-text" : "During BCR signaling, the SRC family kinase LYN phosphorylates the transmembrane protein cluster of differentiation 19, which recruits PI3K to the BCR."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-155-106",
    "text" : "BCR signaling, the SRC family kinase LYN phosphorylates",
    "arguments" : [ {
      "text" : "BCR",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-155-701"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28074,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28019,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-155",
    "found-by" : "Phosphorylation_syntax_3a_verb",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-154-46" ],
    "verbose-text" : "During BCR signaling, the SRC family kinase LYN phosphorylates the transmembrane protein cluster of differentiation 19, which recruits PI3K to the BCR."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-155-20",
    "text" : "phosphorylates the transmembrane protein",
    "arguments" : [ {
      "text" : "transmembrane protein",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-155-19"
    } ],
    "type" : "protein-modification",
    "frame-type" : "event-mention",
    "subtype" : "phosphorylation",
    "is-direct" : true,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28100,
      "object-type" : "relative-pos"
    },
    "trigger" : "phosphorylates",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28060,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-155",
    "found-by" : "Phosphorylation_syntax_1a_verb",
    "verbose-text" : "During BCR signaling, the SRC family kinase LYN phosphorylates the transmembrane protein cluster of differentiation 19, which recruits PI3K to the BCR."
  }, {
    "text" : "LYN phosphorylates the transmembrane protein",
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-155-21",
    "arguments" : [ {
      "text" : "phosphorylates the transmembrane protein",
      "argument-type" : "event",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "evem-PMC4712330-UAZ-r1-PMC4712330-155-20"
    }, {
      "text" : "LYN",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-155-21"
    } ],
    "type" : "regulation",
    "frame-type" : "event-mention",
    "subtype" : "positive-regulation",
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28100,
      "object-type" : "relative-pos"
    },
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 28056,
      "object-type" : "relative-pos"
    },
    "found-by" : "Phosphorylation_syntax_1a_verb + toRelationMention",
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-155",
    "verbose-text" : "During BCR signaling, the SRC family kinase LYN phosphorylates the transmembrane protein cluster of differentiation 19, which recruits PI3K to the BCR."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-163-162",
    "text" : "BCR signaling in GCB-DLBCL",
    "arguments" : [ {
      "text" : "GCB-DLBCL",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-163-739"
    }, {
      "text" : "BCR",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-163-738"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 29669,
      "object-type" : "relative-pos"
    },
    "trigger" : "signaling",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 29643,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-163",
    "found-by" : "Positive_activation_syntax_3_noun",
    "verbose-text" : "Briefly, the “chronic” BCR signaling in ABC-DLBCL is characterized by the many pathways involved with the CARD11-mediated activation of NF-κB signaling, whereas the “tonic” BCR signaling in GCB-DLBCL is characterized by the constitutive activation of PI3K in promoting survival [96, 97]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-164-61",
    "text" : "enhance the treatment response of PTEN-deficient tumors.THERAPIES TARGETING FUNCTIONAL LOSS OF PTEN IN LYMPHOMAPI3K/AKT/mTOR pathway inhibitorsOwing to PI3K's critical roles in human cancers, PI3K",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-164-743"
    }, {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-164-747"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 30050,
      "object-type" : "relative-pos"
    },
    "trigger" : "enhance",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 29854,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-164",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Given these findings, the combination of PI3K pathway inhibitors with BCR pathway inhibitors may enhance the treatment response of PTEN-deficient tumors.THERAPIES TARGETING FUNCTIONAL LOSS OF PTEN IN LYMPHOMAPI3K/AKT/mTOR pathway inhibitorsOwing to PI3K's critical roles in human cancers, PI3K targeting is one of the most promising areas of anticancer therapy development."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-164-55",
    "text" : "LOSS OF PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-164-744"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "decreaseamount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 29953,
      "object-type" : "relative-pos"
    },
    "trigger" : "LOSS",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 29941,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-164",
    "found-by" : "decrease_amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-164-51" ],
    "verbose-text" : "Given these findings, the combination of PI3K pathway inhibitors with BCR pathway inhibitors may enhance the treatment response of PTEN-deficient tumors.THERAPIES TARGETING FUNCTIONAL LOSS OF PTEN IN LYMPHOMAPI3K/AKT/mTOR pathway inhibitorsOwing to PI3K's critical roles in human cancers, PI3K targeting is one of the most promising areas of anticancer therapy development."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-164-105",
    "text" : "PI3K pathway inhibitors with BCR pathway inhibitors may enhance the treatment response of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-164-743"
    }, {
      "text" : "PI3K",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-164-741"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 29892,
      "object-type" : "relative-pos"
    },
    "trigger" : "enhance",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 29798,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-164",
    "found-by" : "Positive_activation_syntax_1_verb",
    "verbose-text" : "Given these findings, the combination of PI3K pathway inhibitors with BCR pathway inhibitors may enhance the treatment response of PTEN-deficient tumors.THERAPIES TARGETING FUNCTIONAL LOSS OF PTEN IN LYMPHOMAPI3K/AKT/mTOR pathway inhibitorsOwing to PI3K's critical roles in human cancers, PI3K targeting is one of the most promising areas of anticancer therapy development."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-174-85",
    "text" : "PI3K inhibitors have been shown to repress the viability of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-174-792"
    }, {
      "text" : "PI3K inhibitors",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-174-791"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31493,
      "object-type" : "relative-pos"
    },
    "trigger" : "repress",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31429,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-174",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "mTOR inhibitors include everolimus and temsirolimus.In addition to PI3K pan-inhibition, several isoform-selective PI3K inhibitors have been shown to repress the viability of PTEN-deficient tumors."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-174-109",
    "text" : "PI3K inhibitors have been shown to repress the viability of PTEN-deficient tumors",
    "arguments" : [ {
      "text" : "tumors",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-174-793"
    }, {
      "text" : "PI3K inhibitors",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-174-791"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31510,
      "object-type" : "relative-pos"
    },
    "trigger" : "repress",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31429,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-174",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "mTOR inhibitors include everolimus and temsirolimus.In addition to PI3K pan-inhibition, several isoform-selective PI3K inhibitors have been shown to repress the viability of PTEN-deficient tumors."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-175-136",
    "text" : "p110β-specific PI3K inhibitor AZD6482 (KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-798"
    }, {
      "text" : "p110",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-794"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-negated" : true,
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31671,
      "object-type" : "relative-pos"
    },
    "trigger" : "block",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31525,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-175",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "Notably, the p110β-specific PI3K inhibitor AZD6482 (KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN–wild-type tumors in mouse models [98]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-175-135",
    "text" : "p110β-specific PI3K inhibitor AZD6482 (KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN–wild-type tumors",
    "arguments" : [ {
      "text" : "tumors",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-799"
    }, {
      "text" : "p110",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-794"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "positive-activation",
    "is-negated" : true,
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31688,
      "object-type" : "relative-pos"
    },
    "trigger" : "block",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31525,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-175",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "Notably, the p110β-specific PI3K inhibitor AZD6482 (KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN–wild-type tumors in mouse models [98]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-175-110",
    "text" : "KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN–wild-type tumors",
    "arguments" : [ {
      "text" : "tumors",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-799"
    }, {
      "text" : "KIN-193",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-796"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-negated" : true,
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31688,
      "object-type" : "relative-pos"
    },
    "trigger" : "block",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31564,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-175",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "Notably, the p110β-specific PI3K inhibitor AZD6482 (KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN–wild-type tumors in mouse models [98]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-175-111",
    "text" : "KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN",
    "arguments" : [ {
      "text" : "PTEN",
      "argument-type" : "entity",
      "type" : "controlled",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-798"
    }, {
      "text" : "KIN-193",
      "argument-type" : "entity",
      "type" : "controller",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-175-796"
    } ],
    "type" : "activation",
    "frame-type" : "event-mention",
    "subtype" : "negative-activation",
    "is-negated" : true,
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31671,
      "object-type" : "relative-pos"
    },
    "trigger" : "block",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 31564,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-175",
    "found-by" : "Negative_activation_syntax_1_verb",
    "verbose-text" : "Notably, the p110β-specific PI3K inhibitor AZD6482 (KIN-193) displayed remarkable antitumor activity in PTEN-null tumors but failed to block the growth of PTEN–wild-type tumors in mouse models [98]."
  }, {
    "frame-id" : "evem-PMC4712330-UAZ-r1-PMC4712330-183-90",
    "text" : "PIP3 levels",
    "arguments" : [ {
      "text" : "PIP3",
      "argument-type" : "entity",
      "type" : "theme",
      "object-type" : "argument",
      "index" : 0,
      "arg" : "ment-PMC4712330-UAZ-r1-PMC4712330-183-830"
    } ],
    "type" : "amount",
    "frame-type" : "event-mention",
    "subtype" : "amount",
    "is-direct" : false,
    "end-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 33250,
      "object-type" : "relative-pos"
    },
    "trigger" : "levels",
    "object-type" : "frame",
    "start-pos" : {
      "reference" : "pass-PMC4712330-UAZ-r1-PMC4712330",
      "offset" : 33239,
      "object-type" : "relative-pos"
    },
    "sentence" : "sent-PMC4712330-UAZ-r1-PMC4712330-183",
    "found-by" : "amount_1",
    "context" : [ "cntx-PMC4712330-UAZ-r1-PMC4712330-0-1" ],
    "verbose-text" : "It is clear that PTEN is far more than a cytosolic protein that acts as a lipid phosphatase to maintain PIP3 levels."
  } ],
  "object-type" : "frame-collection",
  "object-meta" : {
    "processing-end" : "2023-03-18T23:39:38Z",
    "doc-id" : "PMC4712330",
    "component-type" : "machine",
    "component" : "Reach",
    "processing-start" : "2023-03-18T23:34:06Z",
    "object-type" : "meta-info",
    "organization" : "UAZ"
  }
}